Biodesix raises 2026 revenue outlook to $108M-$114M as it targets sustained adjusted EBITDA profitability (NASDAQ:BDSX)
Earnings Name Insights: Biodesix (BDSX) Q1 2026 Administration view Scott Hutton (President, CEO & Director) described Q1 as “an distinctive ...
-1024x683.jpg?w=120&resize=120,86&ssl=1 "US-Iran Peace: Done or Delayed?")
